Tresiba
Payments companies reported to CMS as associated with Tresiba. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tresiba, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tresiba
These are the largest totals companies reported as associated with Tresiba. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Bergenstal | St Louis Park, MN | Endocrinology, Diabetes & Metabolism | $6,000.00 |
| Emily Neely | Nashville, TN | Endocrinology, Diabetes & Metabolism | $620.45 |
| Bettina Engh | Nashville, TN | Nurse Practitioner | $530.31 |
| Annis Marney | Nashville, TN | Endocrinology, Diabetes & Metabolism | $529.64 |
| Amanda Daniel | Nashville, TN | Endocrinology, Diabetes & Metabolism | $522.33 |
| David Sutton | Jacksonville, FL | Endocrinology, Diabetes & Metabolism | $508.48 |
| Cherish Holt | Nashville, TN | Nurse Practitioner | $501.08 |
| Ricardo Silva | Jacksonville, FL | Endocrinology, Diabetes & Metabolism | $498.85 |
| Wasim Deeb | Jacksonville, FL | Endocrinology, Diabetes & Metabolism | $482.54 |
| Michael Carlson | Nashville, TN | Endocrinology, Diabetes & Metabolism | $462.98 |
Prescribed Tresiba?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.